Insightful analysis and commentary for the US and global equity investor
Contributors: Douglas McIntyre Jon C. Ogg

Previous Posts

Monday, August 28, 2006

Generic CIPRO Injections Filed

The US FDA today approved several Abbreviated New Drug Applications (ANDAs) for generic versions of Bayer Corporation (BAY-NYSE/ADR) Pharmaceutical Division's CIPRO I.V., a drug to treat certain bacterial infections. It has been prescribed for more than 340 million patients worldwide.

Ciprofloxacin (sip-row-FLOX-a-sin) Injection, USP, is indicated for the treatment of many infections, including pneumonias, bone and joint infections, complicated intraabdominal infections, skin and skin structure infections, and therapy of patients with fever, and even anthrax.

Powered by Blogger